Related Experiment Video
Updated: Jul 18, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
The challenges of chronic obstructive pulmonary diseases (COPD)--a perspective
R William Vandivier1, Norbert F Voelkel
1Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Health Sciences Center, 4200 E. Ninth Avenue, C272, Denver, Colorado 80220, USA. vandivierb@njc.org
COPD
|December 2, 2006
Summary
Chronic Obstructive Pulmonary Disease (COPD), a major global health issue, requires deeper understanding of its biological causes for better treatments. This review explores challenges in COPD pathogenesis, risk factors, and novel management strategies.
Area of Science:
- Pulmonary Medicine
- Immunology
- Chronic Disease Research
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a significant global health concern, projected to be the third leading cause of death worldwide.
- Current understanding of COPD's biological mechanisms is incomplete, limiting the effectiveness of existing therapies.
- Cigarette smoke is the primary etiological factor driving this progressive inflammatory lung disease.
Purpose of the Study:
- To review the current challenges in understanding COPD pathogenesis.
- To explore the roles of impaired tissue repair and adaptive immunity in COPD.
- To discuss COPD phenotypes, biomarkers, and strategies for disease management and exacerbation prevention.
Main Methods:
- Literature review focusing on recent advancements in COPD research.
- Analysis of biological underpinnings, including tissue repair and immune responses.
- Synthesis of information on risk factors, phenotypes, biomarkers, and therapeutic approaches.
Main Results:
- Incomplete understanding of COPD pathogenesis hinders effective treatment development.
- Impaired tissue repair and adaptive immunity are key contributors to disease progression.
- Identification of potential biomarkers and diverse COPD phenotypes is crucial.
Conclusions:
- Addressing knowledge gaps in COPD biology is essential for improving patient outcomes.
- New therapeutic strategies are needed for effective chronic disease management and prevention of exacerbations.
- Findings in COPD research have broader implications for other chronic inflammatory diseases.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: